论文部分内容阅读
卵巢透明细胞癌常合并盆腔子宫内膜异位症(EM),为评价卵巢透明细胞癌与盆腔子宫内膜异位之间临床病理的相关性,对1984～1995年间Keio大学医院妇产科收治首次治疗的原发性卵巢癌日本患者325例,其中卵巢透明细胞癌53例平均年龄51,1(39～76)岁。所有患者首次手术时均行卵巢癌细胞减灭术,残留肿瘤大小均小于2cm。术后除2例外均接受含顺铂的联合化疗。本研究中,合并盆腔子宫内膜异位的卵巢透明细胞癌指:①同一卵巢组织病理证实同时存在卵巢透明细胞癌及异位的子宫内
Ovarian clear cell carcinoma often associated with pelvic endometriosis (EM), in order to evaluate the ovarian clear cell carcinoma and pelvic endometriosis clinical pathological correlation between 1984 to 1995 Keio University Hospital Obstetrics and Gynecology The first treatment of primary ovarian cancer in 325 patients with Japanese patients, of which 53 cases of ovarian clear cell carcinoma with an average age of 51,1 (39 to 76) years old. All patients underwent ovarian cancer cytoreductive surgery at the first operation, the residual tumor size was less than 2cm. All except 2 patients received cisplatin combined with chemotherapy. In this study, pelvic ovarian clear cell carcinoma combined pelvic endometriosis refers to: ① the same ovarian tissue pathology confirmed the existence of ovarian clear cell carcinoma and ectopic uterus